Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa

Emerging Infectious Diseases

Volumn 4, Issue 2, 1998, Pages 277-281

  Widdowson, Carol A ^a   Klugman, Keith P ^a  

^a NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; PENICILLIN DERIVATIVE; STREPTOGRAMIN;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATION; GENE ISOLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RESISTANCE; PHENOTYPE; REVIEW; SERODIAGNOSIS; SOUTH AFRICA; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0031863184     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0402.980216     Document Type: Review

References (28)

1. Dixon JMS. Pneumococcus resistant to erythromycin and lincomycin. Lancet 1967;i:573.
2. Jacobs MR, Koornhof HJ, Robins-Browne RM, Stevenson CM, Vermaak ZA, Freiman I, et al. Emergence of multiply resistant pneumococci. N Engl J Med 1978;299:735-40.
3. Lai C-J, Weisblum B. Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus. Proc Natl Acad Sci U S A 1971;68:856.
4. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 1995;39:577-85.
5. Trieu-Cuot P, Poyart-Salmeron C, Carlier C, Courvalin P. Nucleotide sequence of the erythromycin resistance gene of the conjugative transposon Tn1545. Nucleic Acids Res 1990;18:3660.
6. Horinouchi S, Byeon WH, Weisblum B. A complex attenuator regulates inducible resistance to macrolides, lincosamides, and streptogramin type B antibiotics in Streptococcus sanguis. J Bacteriol 1983;154:1252-62.
7. Sutcliffe J, Tait-Kamradt A, Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 1996;40:1817-24.
8. Tait-Kamradt A, Clancy J, Cronan M, Dib-Hajj F, Wondrack L, Yuan W, et al. mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob Agents Chemother 1997;41:2251-5.
9. Fernandez-Muñoz R, Monro RE, Torres-Pinedo R, Vasquez D. Substrate- and antibiotic-binding sites at the peptidyl-transferase centre of Escherichia coli ribosomes. Studies on the chloramphenicol, lincomycin and erythromycin sites. Eur J Biochem 1971;23:185-93.
10. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disc susceptibility tests. 6th ed. Wayne (PA): The Committee; 1997.
11. Paton JC, Berry AM, Lock RA, Hansman D, Manning PA. Cloning and expression in Escherichia coli of the Streptococcuspneumoniae gene encodingpneumolysin. Infect Immun 1986;54:50-5.
12. Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 1996;40:2562-6.
13. Robbins JB, Austrian R, Lee C-J, Rastogi SC, Schiffman G, Henrichsen J, et al. Considerations for formulating the second generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis 1983;148:1136-59.
14. Gray BM, Converse GM III, Dillon HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980;142:923-33.
15. Friedland IR, Klugman KP. Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet 1992;339:405-8.
16. Ednie LM, Spangler SK, Jacobs MR, Appelbaum PC. Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents. Antimicrob Agents Chemother 1997;41:1033-6.
17. Reichler MR, Rakovsky J, Sobotová A, Sláciková M, Hlavácová B, Hill B, et al. Multiple antimicrobial resistance of pneumococci in children with otitis media, bacteremia, and meningitis in Slovakia. J Infect Dis 1995;171:1491-6.
18. Gür D, Ünal S, Akalin HE. Resistance patterns in Turkey. Internat J Antimicrob Agents 1995;6:23-6.
19. Goldstein FW, Acar JF, The Alexander Project Collaborative Group. Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992-93 Western Europe and USA collaborative study. J Antimicrob Chemother 1996;38:71-84.
20. Aszkenasy OM, George RC, Begg NT. Pneumococcal bacteraemia and meningitis in England and Wales 1982 to 1992. Commun Dis Rep CDR Rev 1995;5:R45-R50.
21. Doern GV, Brueggemann AB, Holley Jr HP, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-year national surveillance study. Antimicrob Agents Chemother 1996;40:1208-13.
22. Butler JC, Hofmann J, Cetron MS, Elliott JA, Facklam RR, Breiman RF, et al. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Surveillance System. J Infect Dis 1996;174:986-93.
23. Vaz Pato MV, Belo de Carvalho C, Tomasz A, the Multicenter Study Group. Antibiotic susceptibility of Streptococcus pneumoniae isolates in Portugal. A multicenter study between 1989 and 1993. Microb Drug Resist 1995;1:59-69.
24. Klugman KP, Koornhof HJ, Kuhnle V. Clinical and nasopharyngeal isolates of unusual multiply resistant pneumococci. The American Journal of Diseases of Children 1986;140:1186-90.
25. Visalli MA, Jacobs MR, Appelbaum PC. Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin. Antimicrob Agents Chemother 1997;41:1867-70.
26. Pankuch GA, Lichtenberger C, Jacobs MR, Appelbaum PC. Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies. Antimicrob Agents Chemother 1996;40:1653-6.
27. Barry AL, Fuchs PC. In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens. Antimicrob Agents Chemother 1995;39:238-40.
28. Burucoa C, Pasdeloup T, Chapon C, Fauchère JL, Robert R. Failure of pristinamycin treatment in a case of pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis 1995;14:341-2.